Mediera Corporation (TPEX:5398)
14.20
+0.25 (1.79%)
Aug 19, 2026, 1:09 PM CST
Mediera Revenue
Mediera had revenue of 39.15M TWD in the quarter ending June 30, 2026, a decrease of -48.77%. This brings the company's revenue in the last twelve months to 195.89M, down -17.19% year-over-year. In the year 2025, Mediera had annual revenue of 229.85M, down -3.62%.
Revenue (ttm)
195.89M
Revenue Growth
-17.19%
P/S Ratio
3.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
690.04M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 229.85M | -8.64M | -3.62% |
| Dec 31, 2024 | 238.48M | 45.59M | 23.63% |
| Dec 31, 2023 | 192.90M | -64.65M | -25.10% |
| Dec 31, 2022 | 257.55M | -94.01M | -26.74% |
| Dec 31, 2021 | 351.56M | -16.33M | -4.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Prince Pharmaceutical | 1.06B |
| Excelsior Biopharma | 936.92M |
| Anxo Pharmaceutical | 878.88M |
| DV Biomed | 795.19M |
| GeneFerm Biotechnology | 664.94M |
| Winston Medical Supply | 632.80M |
| Bioray Biotech | 222.73M |
| General Biologicals | 215.74M |